We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Abbott Settles TriCor Class Action For $184M

Law360 (November 20, 2008, 12:00 AM EST) -- After several years of hard-fought litigation, Abbott Laboratories has agreed to pay $184 million to settle antitrust claims by rival pharmaceutical companies, drug stores and other purchasers that the company profited by unfairly blocking a generic version of the blockbuster cholesterol drug TriCor from the market.

The settlement resolves allegations by competitors Teva Pharmaceuticals and Impax Laboratories Inc. that Abbott conspired with its French partner Fournier Industrie et Sante to launch frivolous lawsuits to fence off the market and prevent competition for TriCor.

Abbott and Fournier...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.